CTH120 First-in-Human Study: Single and Multiple Ascending Doses and Potential Food Interaction
Status:
COMPLETED
Trial end date:
2024-11-11
Target enrollment:
Participant gender:
Summary
The purpose of this First-in-Human Phase I study is to investigate the safety, tolerability and pharmacokinetics of CTH120 in adult healthy volunteers.
Phase:
PHASE1
Details
Lead Sponsor:
Connecta Therapeutics, S.L.
Collaborators:
Adknoma Health Research Hospital del Mar Research Institute (IMIM) Ministry of Science and Innovation, Spain